Chief Commercial Officer · ARS Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$250K
Shares
25.0K
Price
$10
Executed
Jun 12, 2026
Disclosed
Jun 12, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jun 12 executedJun 12, 2026 disclosed
SPRY · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Karas Eric filed this Form 4 reporting a open-market sale of SPRY on Jun 12, 2026. It became public on Jun 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Karas Ericcik:0001951287
Issuer
ARS Pharmaceuticals, Inc.cik:0001671858
Revision history · 0
No field has changed since this record was first ingested.
